Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The role of B cells in blood pressure regulation and hypertension
EF 2020-21
Résumé
Hypertension (HTN) is a disease that affects one third of the adult population. The development of HTN has traditionally been attributed to dysfunctions of the kidneys, blood vessels, or imbalances of specific hormones in the body. Recently however, there is growing interest about the role of the immune system in blood pressure (BP) control and HTN, but how this occurs is not fully understood. Our lab has shown that B cells, a type of immune cell, are important for BP control: genetically-modified mice born with permanent B cell deficiency have lower BP than normal mice. They also have increased urinary sodium and water excretion (which is known to decrease BP) and reduced expression of vasopressin receptor-2 (V2R), a kidney protein that promotes sodium and water retention. We hypothesize that B cell deficiency reduces kidney V2R expression, which elevates sodium and water excretion, and lowers blood volume and BP. In this project, we will examine if B cells causally affect BP through alterations in kidney function using a mouse model in which B cells are only depleted after giving diphtheria toxin injections. We will examine if these mice develop decreased BP due to elevated sodium and water excretion, and whether they are resistant to experimental HTN. We also aim to explore the molecular mechanism by which this occurs. Computational analyses suggest that V2R expression in the kidneys is initiated by the NF-kB signalling pathway, a commonly used mechanism in immune cells. Our preliminary data has shown activation of the NF-kB pathway by B cell-produced factors, suggesting regulation of V2R by B cells. Understanding how B cells control BP and kidney function would help us identify new causes of HTN, and possibly lead to HTN treatments that target B cells.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449578
Name
Zhou Xueyang
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of B cells in blood pressure regulation and hypertension
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
B Cells; Blood Pressure; Cardiovascular Physiology; Cell Depletion Model; Hypertension; Immortalized Cell Line; Immunology; Renal Physiology; Transcriptional Regulation; Vasopressin
Abstract
Hypertension (HTN) is a disease that affects one third of the adult population. The development of HTN has traditionally been attributed to dysfunctions of the kidneys, blood vessels, or imbalances of specific hormones in the body. Recently however, there is growing interest about the role of the immune system in blood pressure (BP) control and HTN, but how this occurs is not fully understood. Our lab has shown that B cells, a type of immune cell, are important for BP control: genetically-modified mice born with permanent B cell deficiency have lower BP than normal mice. They also have increased urinary sodium and water excretion (which is known to decrease BP) and reduced expression of vasopressin receptor-2 (V<sub>2</sub>R), a kidney protein that promotes sodium and water retention. We hypothesize that B cell deficiency reduces kidney V<sub>2</sub>R expression, which elevates sodium and water excretion, and lowers blood volume and BP. In this project, we will examine if B cells causally affect BP through alterations in kidney function using a mouse model in which B cells are only depleted after giving diphtheria toxin injections. We will examine if these mice develop decreased BP due to elevated sodium and water excretion, and whether they are resistant to experimental HTN. We also aim to explore the molecular mechanism by which this occurs. Computational analyses suggest that V<sub>2</sub>R expression in the kidneys is initiated by the NF-kB signalling pathway, a commonly used mechanism in immune cells. Our preliminary data has shown activation of the NF-kB pathway by B cell-produced factors, suggesting regulation of V<sub>2</sub>R by B cells. Understanding how B cells control BP and kidney function would help us identify new causes of HTN, and possibly lead to HTN treatments that target B cells.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhou, Xueyang
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~